TL;DR: F0561-0823 (CAS 1019104-01-8) is a chemical compound with molecular formula C20H18ClN3O4S and molecular weight 431.07065 g/mol, supplied by CoreyChem (Career Henan Chemical Co., Ltd.) with ISO-certified quality and global shipping.
N-[2-(3-chlorophenyl)-5-oxo-4,6-dihydrothieno[3,4-c]pyrazol-3-yl]-3,4-dimethoxybenzamide
Also Known As: F0561-0823, N-[2-(3-chlorophenyl)-5-oxo-4,6-dihydrothieno[3,4-c]pyrazol-3-yl]-3,4-dimethoxybenzamide, N-(2-(3-chlorophenyl)-5-oxido-4,6-dihydro-2H-thieno[3,4-c]pyrazol-3-yl)-3,4-dimethoxybenzamide, N-[2-(3-chlorophenyl)-5-oxo-2H,4H,6H-5lambda4-thieno[3,4-c]pyrazol-3-yl]-3,4-dimethoxybenzamide
| Molecular Formula | C20H18ClN3O4S |
| Molecular Weight | 431.07065 g/mol |
| XLogP | 2.4 |
| Topological Polar Surface Area (TPSA) | 102.0 Ų |
| Hydrogen Bond Donors | 1 |
| Hydrogen Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Exact Mass | 431.07065 Da |
| Heavy Atoms | 29 |
| Complexity | 627.0 |
| SMILES | COC1=C(C=C(C=C1)C(=O)NC2=C3CS(=O)CC3=NN2C4=CC(=CC=C4)Cl)OC |
| InChIKey | PTJDUAIWVPUSJY-UHFFFAOYSA-N |
The XLogP value of 2.4 suggests moderate lipophilicity, balancing water solubility and membrane permeability for F0561-0823. The TPSA of 102.0 Ų falls within the moderate polarity range, balancing permeability and solubility for F0561-0823. Following Lipinski's Rule of Five, F0561-0823 has 1 hydrogen bond donor(s) and 6 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
The CAS number of F0561-0823 is 1019104-01-8.
The molecular formula of F0561-0823 is C20H18ClN3O4S.
The molecular weight of F0561-0823 is 431.07065 g/mol.
You can request a quote for F0561-0823 directly from CoreyChem. Contact us or email [email protected] for pricing and availability.
Yes, CoreyChem provides custom synthesis services for F0561-0823 and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.
Request a quote for CAS 1019104-01-8. Our professional technical team will respond with pricing and lead time.